1-33519551-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001281956.2(CSMD2):āc.10863G>Cā(p.Glu3621Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001281956.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSMD2 | NM_001281956.2 | c.10863G>C | p.Glu3621Asp | missense_variant | 70/71 | ENST00000373381.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSMD2 | ENST00000373381.9 | c.10863G>C | p.Glu3621Asp | missense_variant | 70/71 | 1 | NM_001281956.2 | P2 | |
CSMD2 | ENST00000373388.7 | c.10431G>C | p.Glu3477Asp | missense_variant | 69/70 | 1 | |||
CSMD2 | ENST00000619121.4 | c.10743G>C | p.Glu3581Asp | missense_variant | 70/71 | 5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152080Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251476Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135912
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461850Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727220
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152080Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.10431G>C (p.E3477D) alteration is located in exon 69 (coding exon 69) of the CSMD2 gene. This alteration results from a G to C substitution at nucleotide position 10431, causing the glutamic acid (E) at amino acid position 3477 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at